ConductScience.org, home

Paper39232245

The pathogenesis of IgA nephropathy and implications for treatment.

Cheung CK and 5 others. Nat Rev Nephrol, 2025. Cited by 164 papers, by iCite.

Cite this record

ConductScience Library. The pathogenesis of IgA nephropathy and implications for treatment. Papers, record 39232245. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39232245

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The pathogenesis of IgA nephropathy and implications for treatment.
PubMed
Journal
Nat Rev Nephrol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
164
iCite
Relative citation ratio, by iCite
48.73, provisional
iCite
Revised in PubMed
2025-07-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cheung CKChee Kay
2Alexander SSuceena
3Reich HNHeather N
4Selvaskandan HHaresh
5Zhang HHong
6Barratt JJonathanhttps://orcid.org/0000-0002-9063-7229

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Glomerulonephritis, IGAMajor topic
Humans
Immunoglobulin A
Complement Activation
B-Cell Activating Factor
B-Lymphocytes
Tumor Necrosis Factor Ligand Superfamily Member 13

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
IA/CPHS/22/1/506541DBT-Wellcome Trust India AllianceIndiaPubMed

Source PubMed

Download CSV of grants

References175

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137591292Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.Lancet2023https://conductscience.org/library/papers/37591292PubMed
237914086Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy.Kidney Int2024https://conductscience.org/library/papers/37914086PubMed
338344739Novel Treatment Paradigms: Primary IgA Nephropathy.Kidney Int Rep2024https://conductscience.org/library/papers/38344739PubMed
491839IgA immune complexes in Henoch-Schönlein purpura.Lancet1979https://conductscience.org/library/papers/91839PubMed
538552841A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy.Kidney Int2024https://conductscience.org/library/papers/38552841PubMed
630612739Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10.Cell2019https://conductscience.org/library/papers/30612739PubMed
738025243Targeting the Endothelin A Receptor in IgA Nephropathy.Kidney Int Rep2023https://conductscience.org/library/papers/38025243PubMed
83409549The bone marrow as production site of the IgA deposited in the kidneys of patients with IgA nephropathy.Clin Exp Immunol1988https://conductscience.org/library/papers/3409549PubMed
916757497IgA-containing immune complexes in the urine of IgA nephropathy patients.Nephrol Dial Transplant2006https://conductscience.org/library/papers/16757497PubMed
1015156532Recurrent IgA nephropathy after renal transplantation.Semin Nephrol2004https://conductscience.org/library/papers/15156532PubMed
112063851The fate of aggregated immunoglobulin A injected in IgA nephropathy patients and healthy controls.Am J Kidney Dis1991https://conductscience.org/library/papers/2063851PubMed
1233436510Associations of Genetic Variants Contributing to Gut Microbiota Composition in Immunoglobin A Nephropathy.mSystems2021https://conductscience.org/library/papers/33436510PubMed
1336351458Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.Lancet2022https://conductscience.org/library/papers/36351458PubMed
1421949093The pathophysiology of IgA nephropathy.J Am Soc Nephrol2011https://conductscience.org/library/papers/21949093PubMed
1524922509Microbiota and metabolome associated with immunoglobulin A nephropathy (IgAN).PLoS One2014https://conductscience.org/library/papers/24922509PubMed
1627461177The human intestinal B-cell response.Mucosal Immunol2016https://conductscience.org/library/papers/27461177PubMed
176813005Detection of polymeric IgA in glomeruli from patients with IgA nephropathy.Clin Exp Immunol1982https://conductscience.org/library/papers/6813005PubMed
1823739233Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.Kidney Int2013https://conductscience.org/library/papers/23739233PubMed
198157744Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death.J Clin Pathol1993https://conductscience.org/library/papers/8157744PubMed
2036307926The role of complement in glomerulonephritis-are novel therapies ready for prime time?Nephrol Dial Transplant2023https://conductscience.org/library/papers/36307926PubMed

See all 175 referencesDownload CSV of references

Cited by139

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 164 citations.

PMIDTitleJournalYearIn PapersSource
42983718IgA nephropathy in a patient with 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 p. Y329fs mutation: a case report and review.BMC Pediatr2026https://conductscience.org/library/papers/42983718PubMed
42934562Prognostic value of the neutrophil percentage-to-albumin ratio in patients with IgA nephropathy.BMC Nephrol2026https://conductscience.org/library/papers/42934562PubMed
42909805Exosomal C3a initiates the NF-κB-dependent inflammatory axis in IgA nephropathy: a three-phase pilot study integrating clinical, in vivo, and in vitro evidence.Clin Exp Nephrol2026https://conductscience.org/library/papers/42909805PubMed
42903470Single-cell transcriptomic analysis of the terminal ileum identifies BCMA as a therapeutic target in IgA nephropathy.Hlife2026https://conductscience.org/library/papers/42903470PubMed
42899115Efficacy and safety of low-dose telitacicept in IgA nephropathy: a real-world study.Clin Kidney J2026https://conductscience.org/library/papers/42899115PubMed
42840445Mesenchymal stem cells: a potential therapeutic strategy for IgA nephropathy.Front Pharmacol2026https://conductscience.org/library/papers/42840445PubMed
42818608Prognostic value of serum total bilirubin-lipid ratios in patients with IgA nephropathy.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/42818608PubMed
42811306Targeted-release Budesonide (Nefecon) versus systemic glucocorticoids for IgA nephropathy: a placebo-anchored indirect treatment comparison of randomized controlled trials.BMC Nephrol2026https://conductscience.org/library/papers/42811306PubMed
42807446High complement activation index predicts renal progression in crescentic IgA nephropathy.Front Immunol2026https://conductscience.org/library/papers/42807446PubMed
42787250Comparison of efficacy and safety of systemic glucocorticoids and Nefecon in IgA nephropathy patients: a real-world retrospective cohort study.Front Immunol2026https://conductscience.org/library/papers/42787250PubMed
42786735Smoking exposure and long-term progression of IgA nephropathy: a retrospective cohort study of 9,560 patients.Ren Fail2026https://conductscience.org/library/papers/42786735PubMed
42756351Tonsillar Tfh cells contribute to the pathogenesis of IgA nephropathy in collaboration with memory B cells.Front Immunol2026https://conductscience.org/library/papers/42756351PubMed
42746036Post-translational protein S-palmitoylation in renal tubular injury: mechanisms and therapeutic implications.Front Cell Dev Biol2026https://conductscience.org/library/papers/42746036PubMed
42707564From immune dysregulation to renal injury: mechanistic insights and translational opportunities in immune-mediated nephropathies.Front Cell Dev Biol2026https://conductscience.org/library/papers/42707564PubMed
42698355Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy.FASEB J2026https://conductscience.org/library/papers/42698355PubMed
42687161Management strategies for post-transplant IgA nephropathy in kidney transplant recipients: a scoping review.BMC Nephrol2026https://conductscience.org/library/papers/42687161PubMed
42666627Beyond the alarm: unveiling the multifaceted role of IL-33 in kidney disease.Front Immunol2026https://conductscience.org/library/papers/42666627PubMed
42642725A comparative study on the clinicopathological features and short-term prognosis of IgA-dominant infection-related glomerulonephritis and IgA nephropathy.BMC Nephrol2026https://conductscience.org/library/papers/42642725PubMed
42639472Gut-kidney axis in IgA nephropathy: mechanisms linking microbiota dysbiosis to immune dysregulation, Gd-IgA1 generation, and renal injury.Front Immunol2026https://conductscience.org/library/papers/42639472PubMed
42633049Efficacy and safety of sibeprenlimab in IgA nephropathy: interim analysis of the China cohort in the phase 3 VISIONARY trial.Clin Kidney J2026https://conductscience.org/library/papers/42633049PubMed

See all 139 cited byDownload CSV of cited by

Genes46

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C1GALT156913PubTator's text mininghttps://conductscience.org/library/genes/56913NCBI Gene
C1GALT1C129071PubTator's text mininghttps://conductscience.org/library/genes/29071NCBI Gene
C1QA712PubTator's text mininghttps://conductscience.org/library/genes/712NCBI Gene
CCR910803PubTator's text mininghttps://conductscience.org/library/genes/10803NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD79A973PubTator's text mininghttps://conductscience.org/library/genes/973NCBI Gene
CFH3075PubTator's text mininghttps://conductscience.org/library/genes/3075NCBI Gene
CFHR13078PubTator's text mininghttps://conductscience.org/library/genes/3078NCBI Gene
CFHR310878PubTator's text mininghttps://conductscience.org/library/genes/10878NCBI Gene
CFP5199PubTator's text mininghttps://conductscience.org/library/genes/5199NCBI Gene
CHPF79586PubTator's text mininghttps://conductscience.org/library/genes/79586NCBI Gene
CSGALNACT255454PubTator's text mininghttps://conductscience.org/library/genes/55454NCBI Gene
CTNNB11499PubTator's text mininghttps://conductscience.org/library/genes/1499NCBI Gene
CXCL83576PubTator's text mininghttps://conductscience.org/library/genes/3576NCBI Gene
EDN11906PubTator's text mininghttps://conductscience.org/library/genes/1906NCBI Gene
FCAR2204PubTator's text mininghttps://conductscience.org/library/genes/2204NCBI Gene
FN12335PubTator's text mininghttps://conductscience.org/library/genes/2335NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
IGHA13493PubTator's text mininghttps://conductscience.org/library/genes/3493NCBI Gene
IL43565PubTator's text mininghttps://conductscience.org/library/genes/3565NCBI Gene

See all 46 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39232245

GET https://conductscience.org/api/papers/v1/39232245/references?page=2